Literature DB >> 23472999

Impact of fentanyl in lieu of meperidine on endoscopy unit efficiency: a prospective comparative study in patients undergoing EGD.

Ivana Dzeletovic1, M Edwyn Harrison, Michael D Crowell, Francisco C Ramirez, Catherine R Yows, Lucinda A Harris, Shabana F Pasha, Suryakanth R Gurudu, Jonathan A Leighton, Russell I Heigh.   

Abstract

BACKGROUND: Turnaround time is an important component of endoscopy unit efficiency. Any reduction in the total time from patient arrival in the endoscopy room to departure from the recovery area may translate into better endoscopy unit efficiency.
OBJECTIVE: To evaluate the effects on endoscopy unit efficiency of a change in narcotic choice for moderate sedation in patients undergoing EGD at an ambulatory surgery center.
DESIGN: Prospective, comparative, quality-improvement project.
SETTING: Endoscopy unit of a tertiary-care academic medical center. PATIENTS: We enrolled consecutive patients (n = 1963) who underwent outpatient EGD by 1 of 5 endoscopists between November 2008 and November 2010. INTERVENTION: Moderate sedation with midazolam plus fentanyl versus meperidine. MAIN OUTCOME MEASUREMENTS: Sedation-dependent endoscopy unit efficiency and total procedure time (induction-to-intubation, intubation-to-extubation, and extubation-to-discharge).
RESULTS: Fentanyl was associated with reduced total procedure time by 10.1 minutes resulting from both shorter induction-to-intubation time and extubation-to-discharge time (P < .001). The mean (± SD) sedation-dependent endoscopy unit efficiency was 3.2 (± 1.9) procedures per hour for the meperidine group and 3.9 (± 2.7) procedures per hour for the fentanyl group (P = .012); this would translate into possibly increasing the endoscopy suite efficiency by 22%. Based on dosage equivalency conversion, equal doses of fentanyl and meperidine were used. No sedation-related complications or need for reversal agents were recorded. LIMITATIONS: No randomization was performed.
CONCLUSION: Compared with meperidine, fentanyl in combination with midazolam was associated with significantly shorter total procedure time. By improving the turnaround time, sedation-dependent endoscopy unit efficiency may be improved by 22%.
Copyright © 2013 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23472999     DOI: 10.1016/j.gie.2013.01.013

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Comparison of efficacy of meperidine and fentanyl in terms of pain management and quality of life in patients with cervical cancer receiving intracavitary brachytherapy: a double-blind, randomized controlled trial.

Authors:  Saengrawee Thanthong; Sirikorn Rojthamarat; Wipra Worasawate; Phongthara Vichitvejpaisal; Danupon Nantajit; Nantakarn Ieumwananontachai
Journal:  Support Care Cancer       Date:  2017-03-18       Impact factor: 3.603

Review 2.  Sedation in the Endoscopy Suite.

Authors:  Katherine B Hagan; Selvi Thirumurthi; Raju Gottumukkala; John Vargo
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

Review 3.  Studying and Incorporating Efficiency into Gastrointestinal Endoscopy Centers.

Authors:  Lukejohn W Day; David Belson
Journal:  Gastroenterol Res Pract       Date:  2015-05-25       Impact factor: 2.260

4.  Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy.

Authors:  Masahiro Katsurada; Motoko Tachihara; Naoko Katsurada; Naoya Takata; Hiroki Sato; Chihiro Mimura; Junya Yoshioka; Koichi Furukawa; Masako Yumura; Takehiro Otoshi; Yuichiro Yasuda; Tatsunori Kiriu; Daisuke Hazama; Tatsuya Nagano; Masatsugu Yamamoto; Yoshihiro Nishimura; Kazuyuki Kobayashi
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

Review 5.  Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.

Authors:  Brian M Fung; Deanna J Leon; Lauren N Beck; James H Tabibian
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.